Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)

Clinical Trial ID NCT00919009

PubWeight™ 4.16‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00919009

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology 2012 1.33
2 Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. Hepatol Res 2012 1.24
3 Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma. BMC Cancer 2010 0.79
4 Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma. Liver Cancer 2012 0.78
Next 100